FDA Clearance Tracker · P130008-S003
INSPIRE II UPPER AIRWAY STIMULATOR
Last checked: Nov 20, 2026Latest source record: Sep 19, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Sep 19, 2014
Approved
Time to decision
58 days
Received Jul 23, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P130008-S003
- Device name
- INSPIRE II UPPER AIRWAY STIMULATOR
- Applicant
- Inspire Medical Systems
- Applicant location
- Maple Grove, MN
- Received
- Jul 23, 2014
- Decided
- Sep 19, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P130008
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for Inspire Medical Systems
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Inspire Upper Airway Stimulation SystemPMA supplement
P130008-S090 · Decided Jun 8, 2023 · 234 days after receipt · Panel Track
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.